Search Results 901-910 of 17830 for Assay

  1. Clinical Chemistry, Post Ph.D. Fellowship (Minnesota) - Meet Our Fellows

    ... assays while supporting the production lab. I have also served in the Ohio Army National Guard as a medical operations officer since 2015. Why did you chose ...

  2. Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations - Mayo Clinic

    * Identification of one (or more) of the following EGFR mutations by Next Generation Sequencing (NGS) as determined by a local assay performed in a ...

  3. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    ... assay; MSLN expression score using Ventana immunohistochemistry (IHC) SP74 assay; Phase I only: In addition 5- 30% tumor cells and 1, 2, or 3+ MSLN score ...

  4. A Study To Learn About The Effects Of Felzartamab Infusions In Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation - Mayo Clinic

    ... assays within 3 months prior to randomization. Key Exclusion Criteria: * Transplant: Blood type (ABO)-incompatible transplant. * History of multiple organ ...

  5. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

    Serum free light chain assay: Involved free light chain level ≥ 10 milligrams per deciliter (mg/dL) (≥ 100 milligrams per liter [mg/L]) and an abnormal ...

  6. Rectal Cancer Clinical Trials - Mayo Clinic Research

    To evaluate the ability of the plasma MDM assay to predict CRC recurrence when tested serially following curative resection of CRC metastases. Tucatinib and ...

  7. Small Lymphocytic Lymphoma Clinical Trials - Mayo Clinic Research

    TP-0903 has shown potent inhibition of AXL kinase and other TAM family members in a biochemical kinase assay. ... assays to detect cancer early in blood.

  8. Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Confirmed PD-L1-positive SCCHN by Ventana SP263 assay; WHO/ECOG performance status of 0 or 1; At least 1 measurable lesion at baseline; No prior exposure to ...

  9. Publications - Karen S. Anderson, M.D., Ph.D. - Mayo Clinic

    ... assay for JAK2 and PD-L1 amplification. Mod Pathol. 2017 Nov; 30 (11):1516-1526 Epub 2017 July 28. View PubMed; Maley CC, Aktipis A, Graham TA, Sottoriva A ...

  10. Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf® Monitoring - Mayo Clinic

    ... assays. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 6/25/2024. Questions regarding updates should be ...